House Bill 1959
2021-2022 Regular Session
An Act providing for research and clinical studies of psilocybin, for duties of Department of Health, for duties of institutional review boards, for duties of authorized psilocybin manufacturers, for duties of approved investigators and for reports.
Co-Sponsorship Memo
Prime Sponsor

Representative Tracy Pennycuick
R House District 147
Co-Sponsors

Rep. Jennifer O'Mara
D House District 165

Rep. MaryLouise Isaacson
D House District 175

Rep. Tina Davis
D House District 141

Rep. Michael Schlossberg
D House District 132

Rep. Tim Hennessey
R House District 26

Rep. Carrie Lewis DelRosso
R House District 33

Rep. Nancy Guenst
D House District 152

Rep. F. Todd Polinchock
R House District 144

Rep. Matthew Dowling
R House District 51

Rep. Joe Hamm
R House District 84

Rep. Benjamin Sanchez
D House District 153

Rep. Christina Sappey
D House District 158

Rep. Brian Sims
D House District 182

Rep. Timothy J. O'Neal
R House District 48

Rep. Melissa Shusterman
D House District 157

Rep. Karen Boback
R House District 117

Rep. Napoleon J. Nelson
D House District 154

Rep. Aaron Bernstine
R House District 10

Rep. Eric Nelson
R House District 57

Rep. Jeanne McNeill
D House District 133

Rep. Mary Jo Daley
D House District 148

Rep. Christopher Quinn
R House District 168

Rep. Greg Rothman
R House District 87

Rep. P. Sturla
D House District 96
Bill Status & History
Last Action: Referred to Health, Oct. 12, 2021
House
H
S
Printers Numbers
Votes
There are no votes available.
Committee Meetings
Voting meeting on HB 1005, HB 1644, HB 1959, HB 2013, HB 2033, HB2077 and any other business that may come before the committee.
Voting meeting on HB 1005, HB 1644, HB 1959, HB 2013, HB 2033, HB2077 and any other business that may come before the committee.
Statute References
There are no statute references for this bill.
House Bill 1959
2021-2022 Regular Session
Sponsors
PENNYCUICK, O'MARA, ISAACSON, T. DAVIS, SCHLOSSBERG, HENNESSEY, LEWIS DELROSSO, GUENST, POLINCHOCK, DOWLING, HAMM, SANCHEZ, SAPPEY, SIMS, O'NEAL, SHUSTERMAN, BOBACK, N. NELSON, BERNSTINE, E. NELSON, McNEILL, DALEY, QUINN, ROTHMAN, STURLA
Short Title
An Act providing for research and clinical studies of psilocybin, for duties of Department of Health, for duties of institutional review boards, for duties of authorized psilocybin manufacturers, for duties of approved investigators and for reports.
Memo Subject
REVISED - Public Health Benefits of Psilocybin Act
Actions
2260 | Referred to HEALTH, Oct. 12, 2021 |
Generated 04/21/2025 06:04 PM